The pathophysiology, presentation and classification of Type 1 diabetes

Area of Science:

• Endocrinology and Immunology
• Autoimmune Disease Pathogenesis
• Metabolic Disorders

Background:

• Type 1 diabetes (T1D) results from autoimmune destruction of pancreatic beta-cells, causing insulin deficiency.
• While often associated with youth, T1D can manifest at any age, presenting significant clinical heterogeneity.
• Genetic susceptibility, environmental triggers, and autoimmune mechanisms intricately drive T1D pathogenesis.

Purpose of the Study:

• To review the complex interplay of factors contributing to type 1 diabetes development.
• To discuss current diagnostic and classification methods, including autoantibodies and C-peptide.
• To highlight the need for refined diagnostic criteria and personalized therapeutic approaches for T1D.

Main Methods:

• Comprehensive literature review of T1D pathogenesis, clinical presentation, and diagnostic strategies.
• Analysis of genetic, environmental, and autoimmune factors influencing disease onset and progression.
• Examination of diagnostic markers, including autoantibodies and C-peptide levels.

Main Results:

• Significant heterogeneity exists in T1D clinical phenotypes and endotypes, complicating diagnosis.
• Obesity and insulin resistance impact T1D progression and management.
• Current diagnostic criteria may not adequately identify autoimmunity in all T1D cases, especially in adults initially diagnosed with type 2 diabetes.

Conclusions:

• Refined diagnostic criteria are essential for accurate T1D classification, particularly in cases mimicking type 2 diabetes.
• Understanding T1D heterogeneity is crucial for developing tailored therapeutic strategies.
• Future research should focus on identifying triggers and optimizing personalized management for type 1 diabetes.